Work

Upadacitinib, a selective JAK1 inhibitor, for the treatment of steroid refractory chronic graft‐versus‐host disease: A multicentre real‐world study

Year: 2025

Type: article

Study design: Observational Study

Source: British Journal of Haematology

DOI: 10.1111/bjh.20183

Authors: Liting Niu, Minli Hu, Yi Xia, Meng Lv, Daoxing Deng, Leqing Cao, Jun Kong, Yanmin Zhao, Xiaodong Mo

Institutions: Peking University, Peking University People's Hospital, First Affiliated Hospital Zhejiang University

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities

Awards: G1014860934, G1582192228, G6749580927, 基于通用型造血干细胞及骨髓微环境重塑缓解移植物抗宿主病

OpenAlex ID: W4411358092

FWCI: 1.308

Cites: 55

Cited by: 2

Related to: 10